Accumulate Dhanuka Agritech; target Rs 100: Dolat Capital

907 Investors following Dhanuka Agritech. Share this News with them.

0

Like this story, share it with millions of investors on M3

Accumulate Dhanuka Agritech; target Rs 100: Dolat Capital

Dolat Capital is bullish on Dhanuka Agritech and has recommended accumulate rating on the stock with a target price of Rs 100 in its February 9, 2012 research report.

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS Accumulate Bharat Forge; target of Rs 332: Angel Broking Buy Solar Industries; target of Rs 976: KRChoksey Buy ONGC; target of Rs 328: FinQuest Securities ALSO READ See previous views by Dolat Capital See what other Experts & Brokerages are saying about Dhanuka Agritech See messages about Dhanuka Agritech Dhanuka Agritec BSE | NSE 29/05/12 Are Mutual Funds betting on Dhanuka Agritec?

Dolat Capital is bullish on Dhanuka Agritech and has recommended accumulate rating on the stock with a target price of Rs 100 in its February 9, 2012 research report.

"Dhanuka Agritech, topline for Q3FY12 de-grew by 3.7% YoY to Rs 1.1bn, mainly on account of 6% decline in volume off-take due to poor northeast monsoons. Rainfall in key regions of Andhra Pradesh, Karnataka and Maharashtra recorded 40% decline, impacting the revenue contribution from these markets. For 9MFY12, herbicides and fungicides portfolio has shown a muted growth of 5% YoY while the insecticides and PGR portfolio grew by 14% YoY. Top five products for 9MFY12 contributed 31% to the topline. The company's flagship brand Targa Super contributed 14.6% (YTD) to the topline and witnessed a decline of 61% during the quarter. EBITDA margins have declined by 530bps YoY to 11.5% led by higher raw material cost at 52.6% of sales (up 750bps YoY). Lower employee cost (down 40bps YoY) and other expenses (down 190bps YoY) restricted margin contraction to some extent. Lower acreages, increasing fertilizer prices and falling produce prices have reduced average farmer's propensity to spend on specialty products. The resulting shift in focus towards generic products has dented EBITDA margin. Interest expense fell by 3.4% YoY to Rs 19mn. Gross debt as of December 2011 stood at Rs 400mn. Depreciation too declined by 36.5% YoY to Rs 12mn. Tax rate stood lower at 19.5% (Q3FY11: 20.7%). PAT declined by 37% YoY to Rs 78mn."

"Long term growth drivers include strengthening its seeds portfolio (scouting for acquisition) and manufacturing selective technicals, leading to backward integration. DAL enjoys high return ratios owing to its asset-light model. However, given the eminent slowdown in the agrochem industry and slower off-take of high-margin specialty products, we have revised our FY12E/FY13E earnings estimate downwards by 20.5%/19.1%. At CMP, the stock trades at 9x FY12E and 6.9x FY13E earnings. We recommend Accumulate with a revised target price of Rs 100 (8x FY13E earnings)," says Dolat Capital research report.

What stocks does Templeton hold?

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click on the attachment